Cargando…

The Therapeutic Role of Monocyte Chemoattractant Protein-1 in a Renal Tissue Engineering Strategy for Diabetic Patients

In this study we aim to boost the functional output of the intra-kidney islet transplantation for diabetic patients using a tissue engineered polymeric scaffold. This highly porous electrospun scaffold featured randomly distributed fibers composed of polycaprolactone (PCL) and poliglecaprone (PGC)....

Descripción completa

Detalles Bibliográficos
Autores principales:	Yin, Hao, Gao, Ming, Leoni, Lara, Han, Huifang, Zhang, Xing, Fu, Zhiren
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3581514/ https://www.ncbi.nlm.nih.gov/pubmed/23451253 http://dx.doi.org/10.1371/journal.pone.0057635

Ejemplares similares

The therapeutic effect of monocyte chemoattractant protein-1 delivered by an electrospun scaffold for hyperglycemia and nephrotic disorders
por: Yong, Cai, et al.
Publicado: (2014)

A tissue-engineered subcutaneous pancreatic cancer model for antitumor drug evaluation
por: He, Qingyi, et al.
Publicado: (2013)

Serum Monocyte Chemoattractant Protein-1 in Pancreatic Cancer
por: Sullivan, Jennifer, et al.
Publicado: (2011)

Role of Monocyte Chemoattractant Protein-1 in Myocardial Infarction
por: Morimoto, Hajime, et al.
Publicado: (2007)

Endoplasmic reticulum stress in the adipose tissue and monocyte chemoattractant protein‐1 are involved in tacrolimus‐induced diabetes mellitus
por: Sun, Xiaoxia, et al.
Publicado: (2023)

Abnormalities in Monocyte Recruitment and Cytokine Expression in Monocyte Chemoattractant Protein 1–deficient Mice
por: Lu, Bao, et al.
Publicado: (1998)

Monocyte chemoattractant protein-1 in patients with peripheral arterial disease.
por: Petrkova, Jana, et al.
Publicado: (2004)

Urinary Monocyte Chemoattractant Protein-1 in Patients With Alport Syndrome
por: Kashtan, Clifford, et al.
Publicado: (2022)

Serum monocyte chemoattractant protein-1 is a biomarker in patients with diabetes and periodontitis
por: Radhakrishnan, Preethi, et al.
Publicado: (2014)

Serum amyloid A is a chemoattractant: induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes
Publicado: (1994)

Monocyte chemoattractant protein-1 contributes to morphine tolerance in rats with cancer-induced bone pain
por: Liu, Lei, et al.
Publicado: (2017)

Urine Monocyte Chemoattractant Protein-1(UMCP-1) as a Biomarker of Renal Involvement in Systemic Lupus Erythematosus
por: Mirfeizi, Zahra, et al.
Publicado: (2012)

Deficiency for the Chemokine Monocyte Chemoattractant Protein-1 Aggravates Tubular Damage after Renal Ischemia/Reperfusion Injury
por: Stroo, Ingrid, et al.
Publicado: (2015)

Monocyte chemoattractant protein-1 serum levels in ovarian cancer patients
por: Hefler, L, et al.
Publicado: (1999)

Chemoattractant-induced activation of c-fos gene expression in human monocytes
Publicado: (1987)

Influence of HFE variants and cellular iron on monocyte chemoattractant protein-1
por: Mitchell, Ryan M, et al.
Publicado: (2009)

The Potential Role of Monocyte Chemoattractant Protein-1 for Major Depressive Disorder
por: Pae, Chi-Un
Publicado: (2014)

Association between monocyte chemoattractant protein-1 and blood pressure in smokers
por: Komiyama, Maki, et al.
Publicado: (2017)

Sonic hedgehog is a potent chemoattractant for human monocytes: diabetes mellitus inhibits Sonic hedgehog-induced monocyte chemotaxis
por: Dunaeva, Marina, et al.
Publicado: (2009)

Adipocyte progenitor cells initiate monocyte chemoattractant protein-1-mediated macrophage accumulation in visceral adipose tissue
por: Kaplan, Jennifer L., et al.
Publicado: (2015)

Plasma Monocyte Chemoattractant Protein-1 Level as a Predictor of the Severity of Community-Acquired Pneumonia
por: Yong, Kok-Khun, et al.
Publicado: (2016)

Purification and amino acid analysis of two human glioma-derived monocyte chemoattractants
Publicado: (1989)

Monocyte chemoattractant protein-1 promoter polymorphism and plasma levels in alzheimer’s disease
por: Porcellini, Elisa, et al.
Publicado: (2013)

Monocyte chemoattractant protein-1: a proinflammatory cytokine elevated in sarcopenic obesity
por: Lim, Jun Pei, et al.
Publicado: (2015)

Monocyte chemoattractant protein-1 is not required for liver regeneration after partial hepatectomy
por: Wyler, Stephanie L., et al.
Publicado: (2016)

CCL2/Monocyte Chemoattractant Protein 1 and Parathyroid Hormone Action on Bone
por: Siddiqui, Jawed Akhtar, et al.
Publicado: (2017)

Cerebrospinal fluid monocyte chemoattractant protein 1 correlates with progression of Parkinson’s disease
por: Santaella, Anna, et al.
Publicado: (2020)

Decreased Serum Monocyte Chemoattractant Protein-1 (MCP-1) Expression in Patients with Upper Gastrointestinal Bleeding
por: Xing, Guohui, et al.
Publicado: (2019)

Urinary monocyte chemoattractant protein-1 levels and interstitial changes in the renal cortex and their relationship with loss of renal function in renal transplant patients with delayed graft function
por: Moyses Neto, Miguel, et al.
Publicado: (2015)

Monocyte Chemoattractant Protein-1− 2518 A/G Single Nucleotide Polymorphism Might Be Associated with Renal Disease and Thrombocytopenia of SLE
por: Piotrowski, Piotr, et al.
Publicado: (2010)

Regulatory Factor X1 Downregulation Contributes to Monocyte Chemoattractant Protein-1 Overexpression in CD14+ Monocytes via Epigenetic Mechanisms in Coronary Heart Disease
por: Jia, Sujie, et al.
Publicado: (2019)

Effects of Tumor Necrosis Factor-α on Podocyte Expression of Monocyte Chemoattractant Protein-1 and in Diabetic Nephropathy
por: Chung, Choon Hee, et al.
Publicado: (2015)

Monocyte chemoattractant protein-1 affects migration of hippocampal neural progenitors following status epilepticus in rats
por: Hung, Yu-Wen, et al.
Publicado: (2013)

Characterisation of urinary monocyte chemoattractant protein 1: Potential biomarker for patients with overactive bladder
por: Farhan, Bilal, et al.
Publicado: (2019)

Monocyte chemoattractant protein 1 expression and proliferation in primary central nervous system lymphoma
por: Takahashi, Yoshinobu, et al.
Publicado: (2017)

A Synergistic Therapeutic Scheme for Hyperglycemia and Nephrotic Disorders in Diabetes
por: He, Qingyi, et al.
Publicado: (2014)

Human Macrophage–derived Chemokine (MDC), a Novel Chemoattractant for Monocytes, Monocyte-derived Dendritic Cells, and Natural Killer Cells
por: Godiska, Ronald, et al.
Publicado: (1997)

Serum Monocyte Chemoattractant Protein-1 Concentrations Associate With Diabetes Status but Not Arterial Stiffness in Children With Type 1 Diabetes
por: Zineh, Issam, et al.
Publicado: (2009)

Urinary epidermal growth factor, monocyte chemoattractant protein-1 or their ratio as predictors for rapid loss of renal function in type 2 diabetic patients with diabetic kidney disease
por: Satirapoj, Bancha, et al.
Publicado: (2018)

Monocyte Chemoattractant Protein 1 is a Prognostic Marker in ANCA-Associated Small Vessel Vasculitis
por: Ohlsson, Sophie, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_no9pjc2au8v226bqk063rm1r53